Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

By T. Seemungal, G. Donaldson, A. Bhowmik, D. Jeffries, J. Wedzicha. American Journal of Respiratory and Critical Care Medicine, 2000

1,282 citations recorded by the source corpus.

Subfields: Physiology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/d84411c71f9651e7ea9d75ab81d7cce9f52f4b23

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Physiology

1. D. Parums
2. J. Wedzicha
3. T. Seemungal
4. John R. Hurst
5. G. Donaldson
6. T. Wilkinson
7. P. Barnes
8. P. Calverley

In Pulmonary and Respiratory Medicine

1. D. Parums
2. J. Wedzicha
3. T. Seemungal
4. P. Barnes
5. G. Donaldson
6. John R. Hurst
7. T. Wilkinson
8. A. Anzueto

Citations in the corpus

• Human Rhinoviruses (2013, background): “Compared to patients with nonviral causes of AECOPD, fever is more frequent in those with documented viral infection (148, 149).”
• Editorial: Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023 Guidelines for COPD, Including COVID-19, Climate Change, and Air Pollution (2023, positive): “Обострения ХОБЛ являются важными событиями в течении заболевания, так как они: • негативно влияют на качество жизни пациента [144, 391]; • ухудшают симптомы и функцию легких, причем воз" вращение к исходному уровню может занять несколь" ко недель [398]; • ускоряют темп снижения функции легких [399, ”
• Early therapy improves outcomes of exacerbations of chronic obstructive pulmonary disease. (2004, methodology): “Although there is evidence that antibiotics (14) and corticosteroids (15–18) hasten the rate of recovery of certain exacerbations, there are few data in the literature on the effects or importance of the timing of initiation of exacerbation treatment on outcome measures such as recovery time, which ”
• New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. (2002, background): “[1-6] Our understanding of the cause and pathogenesis of these exacerbations is incomplete, and the role of bacterial pathogens is controversial.”
• Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. (2017, background): “At 8 weeks, 20% of patients have not recovered to their preexacerbation state.(244) COPD exacerbations increase susceptibility to additional events.”
• Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. (2007, background): “Conditions that may mimic and/or aggravate exacerbations, including pneumonia, pulmonary embolism, congestive heart failure, cardiac arrhythmia, pneumothorax, and pleural effusion, need to be considered in the differential diagnosis and treated if present (47, 90, 97, 116).”